3 Solid, Low Beta Biotechnology Stocks To Buy On Dip – Seeking Alpha

By Dr. Matthew Watson

3 Solid, Low Beta Biotechnology Stocks To Buy On Dip
Seeking Alpha
In this articles, three solid, large-cap biotechnology stocks with strong fundamentals are presented, including Gilead Sciences, Inc. (GILD), Amgen Inc. (AMGN), and Celgene Corporation (CELG). All three stocks have a strong ROE and a low beta and are ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE-ZEmb7uvSxzrS27Wpq5Cl2S2ELw&url=http://seekingalpha.com/article/1225681-3-solid-low-beta-biotechnology-stocks-to-buy-on-dip?source%3Dgoogle_news



categoriaUncategorized commentoComments Off on 3 Solid, Low Beta Biotechnology Stocks To Buy On Dip – Seeking Alpha | dataMarch 3rd, 2013

About...

This author published 6012 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2025